Boston Scientific Corporation (NYSE:BSX) Earnings Preview

Boston Scientific Corporation (NYSE:BSX) is expected to report a 12.7% increase in EPS and an 18% rise in revenue for the upcoming quarter.Despite a slight downward revision in EPS estimates, the company has a history of exceeding earnings expectations.Financial metrics reveal a P/E ratio of 59.41 and a debt-to-equity ratio of 0.54, indicating moderate debt levels and reasonable liquidity.Boston Scientific Corporation, listed on the NYSE under the symbol BSX, is a prominent player in the medical device indu ...